Investors attending the 22nd Anglonordic Lifescience Conference

AION Labs, Albion VC, Alsa Ventures, ARCH Venture Partners, AXA IM Global Health, Biovision Ventures, BlackRock (Kreos Capital), BNPAM, British Business Bank, Calculus Capital, Claret Capital Partners, CPI Enterprises, DGB Capital, Flerie Invest AB, Foresight Group, Great Stuff Ventures, H Tree Capital, Illumina Ventures, Invest in Equity, JJDC, Kerna Ventures, LongRiver Investments, M Ventures, Maudsley Enterprise, Meltwind, Momentum Biotech, Nodenza Venture Partners, OMX Ventures, OrbiMed, OSE, Peppermint Venture Partners, SPRIM Global Investments, Syncona, The Pioneer Group, Tuspark UK, Zinc.
(37 correct at 30 Jan 2026).